Asparagine - Quantitative - Plasma

Asparagine - Quantitative - Plasma is a specialized laboratory test used to measure the concentration of asparagine in plasma. Asparagine is a non-essential amino acid involved in protein synthesis, nitrogen transport, cellular metabolism, and normal nervous-system function.

Abnormal plasma asparagine levels may be associated with rare inherited metabolic disorders, nutritional abnormalities, liver or kidney dysfunction, altered amino acid metabolism, or certain treatment-related conditions. This test is generally performed as part of a broader metabolic evaluation and must be interpreted with other plasma amino acids, clinical findings, dietary history, and genetic investigations.

Benefits of the Test

• Quantitatively measures asparagine concentration in plasma.
• Supports evaluation of abnormal amino acid metabolism.
• Helps investigate suspected inborn errors of metabolism.
• May support assessment of selected neurological or developmental conditions.
• Complements a comprehensive plasma amino acid profile.
• Provides information for nutritional and metabolic assessment.
• May support treatment monitoring in selected clinical situations.
• Guides further biochemical or genetic investigations.

Why Doctors Recommend This Test

Doctors may recommend this test for individuals with unexplained developmental delay, seizures, intellectual disability, abnormal muscle tone, feeding difficulties, poor growth, recurrent metabolic illness, unusual biochemical findings, or a family history of an inherited metabolic disorder. It may also be requested to investigate an abnormal amino acid profile or monitor asparagine levels during selected treatments.

Preparation Before Test

• Fasting may be required because recent food intake can influence plasma amino acid levels.
• Follow the exact fasting instructions provided by the doctor or laboratory.
• A blood sample is collected and plasma is separated for analysis.
• Inform the doctor about medicines, supplements, nutritional products, and amino acid preparations.
• Do not discontinue prescribed medicines unless instructed by the treating doctor.
• Provide information about recent illness, prolonged fasting, intravenous nutrition, or dietary restrictions.
• Share previous amino acid, metabolic, and genetic-testing reports if available.
• Prompt sample processing, freezing, storage, and transport may be required to preserve accuracy.

Normal Reporting Time

Most Asparagine - Quantitative - Plasma reports at Focus Diagnostics are initiated within 2–3 hours of sample receipt for specimen verification, plasma processing, and specialized analytical workflow preparation. Because this is a specialized quantitative amino acid analysis, final measurement, interpretation, quality review, and reporting may require several working days depending on laboratory schedules and quality assurance procedures.

Who Should Take This Test?

This test may be recommended for:

• Individuals with suspected amino acid metabolism disorders.
• Children with unexplained developmental delay or seizures.
• Patients with an abnormal plasma amino acid profile.
• Individuals with unexplained feeding difficulties or poor growth.
• Patients undergoing evaluation for an inborn error of metabolism.
• People with a family history of a relevant inherited metabolic condition.
• Patients requiring monitoring during selected treatments.
• Individuals advised to undergo testing by a metabolic or genetic specialist.

Detailed Information

Amino acids are the building blocks used by the body to produce proteins, enzymes, hormones, neurotransmitters, and other essential molecules. Asparagine is classified as a non-essential amino acid because the body can normally produce it from other metabolic substances.

Asparagine is synthesized primarily from aspartate and glutamine through the action of the enzyme asparagine synthetase. It contributes to nitrogen transport, protein formation, cellular signalling, and the proper function of several tissues, including the nervous system.

Quantitative plasma testing determines the amount of asparagine present in the blood at the time of collection. The test may be performed independently or as part of a comprehensive plasma amino acid analysis that measures multiple amino acids simultaneously.

Low plasma asparagine may occur in rare disorders affecting asparagine synthesis, including asparagine synthetase deficiency. This inherited condition can be associated with severe neurological abnormalities such as congenital microcephaly, developmental impairment, seizures, and abnormal muscle tone.

Low asparagine may also occur during treatment with medications that reduce circulating asparagine, such as asparaginase used in selected haematological malignancies. When clinically indicated, monitoring may help specialists assess treatment-related biochemical changes.

Elevated asparagine is not specific to one disorder. It may be observed with altered amino acid metabolism, nutritional factors, organ dysfunction, sample-related issues, or secondary metabolic changes. The result alone cannot identify the underlying cause.

Plasma amino acid concentrations can be affected by age, recent meals, fasting duration, illness, hydration, medications, supplements, intravenous nutrition, liver function, kidney function, and specimen handling. Accurate interpretation therefore requires appropriate clinical information.

An abnormal asparagine result generally requires correlation with other plasma amino acids and may lead to additional investigations such as urine amino acids, urine organic acids, acylcarnitine analysis, ammonia, lactate, liver and kidney tests, enzyme assays, cerebrospinal fluid studies, or molecular genetic testing.

Reference intervals may vary according to age, laboratory methodology, and clinical circumstances. Results should always be interpreted by a qualified healthcare professional using the reference range provided in the report.

At Focus Diagnostics, Asparagine Quantitative Plasma testing is performed using validated amino acid analysis methodologies, controlled specimen-processing procedures, and stringent quality assurance standards to provide accurate, reliable, and clinically meaningful results.